📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation (2025)

First Author: Richards-Belle A

Attributed to: Data science and pharmacoepidemiology for outcome improvement in severe mental illness (DS-SMI) funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1004520

Publication URI: http://dx.doi.org/10.1371/journal.pmed.1004520

Type: Journal Article/Review

Parent Publication: PLOS Medicine

Issue: 1